TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 138 | 0 | 37,420 |
Financial expenses | 48 | 175 | 1,926 |
Earnings before taxes | -13,039 | -14,521 | 9,956 |
EBITDA | -11,790 | -12,467 | 14,668 |
Total assets | 377,166 | 327,856 | 356,186 |
Current assets | 85,373 | 76,098 | 123,635 |
Current liabilities | 17,899 | 11,298 | 59,429 |
Equity capital | 356,559 | 315,612 | 287,474 |
- share capital | 6,567 | 3,203 | 1,347 |
Employees (average) | 8 | 8 | 11 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 94.5% | 96.3% | 80.7% |
Turnover per employee | 17 | 0 | 3,402 |
Profit as a percentage of turnover | -9448.6% | 26.6% | |
Return on assets (ROA) | -3.4% | -4.4% | 3.3% |
Current ratio | 477.0% | 673.6% | 208.0% |
Return on equity (ROE) | -3.7% | -4.6% | 3.5% |
Change turnover | 138 | -36,711 | 25,892 |
Change turnover % | -100% | 225% | |
Chg. No. of employees | 0 | -3 | -16 |
Chg. No. of employees % | 0% | -27% | -59% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.